Chad Cowan - 11 Jun 2026 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Reporting relationship: Chief Scientific Officer
Issuer ticker: IPSC
Reported as of: 11 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2026, 19:54:25 UTC
Prior SEC filing: 03 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Douglas Carr, Attorney-in-Fact

Key filing fact

Chad Cowan filed Form 4 for Century Therapeutics, Inc. (IPSC) on 15 Jun 2026.

Key facts

This page summarizes Chad Cowan's Form 4 filing for Century Therapeutics, Inc. (IPSC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Jun 2026, 19:54.

Change

Previous filing in this sequence was filed on 03 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002039294 Primary reporting owner

Cowan Chad

Relationship: Chief Scientific Officer
Address: C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA
Signature: /s/ Douglas Carr, Attorney-in-Fact
Signature date: 15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IPSC transaction

Common Stock

Tax liability

Transaction value
Shares: -358
Change %: -0.03%
Price: $2.24^*
Shares after: 1,175,322
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1

IPSC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,697
Date: 11 Jun 2026
Ownership: By Trust
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Footnote F2

Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.